glp-1 drugs for weight loss pills drugs: Lower dose or oral pill may help sustain GLP-1 Supplement for Weight Management

doi: 10.2337/dc09-1203 55 Elkind-HirschKMarrioneauxOBhushanMVernorDBhushanR

As governments and insurers recognize the economic and healthcare burden of obesity, coverage and accessibility are set to improve, further accelerating market adoption

D.BrandC

The study found that 3.6 million people (14.2% of Medicare beneficiaries) were highly likely to be eligible for Wegovy coverage if Medicare used a more conservative definition of established cardiovascular disease, and up to 15.2 million people (60.9% of beneficiaries) could be eligible if Medicare went with a more liberal definition

Side Effects of Other Medications: Many patients taking Wegovy for weight management may also be taking other medications to help manage the condition

The use of these products carries significant health risks